JQUA JPMorgan U.S. Quality Factor ETF

Expense Ratio
0.12%
Dividend
1.25%
Previous close
$61.80
Est. 12 months change
+18.90%
Projected Price
$73.48

Profitability Metrics

Return on Equity (ROE)
44.60%
Return on Assets (ROA)
11.25%
Return on Invested Capital (ROIC)
32.82%
Weighted Average Cost of Capital (WACC)
9.11%
ROIC - WACC
23.71%
Updated : 2026-04-04 07:04 ET

Valuation Metrics

P/E Ratio
24.94
Forward P/E
18.23
PEG Ratio
2.33
Debt Current Ratio
1.84

Growth & Cash Flow

Gross Margin
57.05%
Operating Margin
27.53%
FCF Margin
23.37%
TTM Revenue Growth
15.50%
Projected 12M EPS Growth
36.81%

Price Change

Price % from 50 SMA
-2.29%
Price % from 200 SMA
-0.93%
6 Months
-2.12%
1 Year
8.48%
2 Years
18.14%
The above metrics represent weighted averages, calculated using each stock's individual value weighted by its proportion of ETF holdings.

Top 10 Holdings

Stock TickerWeight
XOM2.17%
AAPL2.09%
GOOGL2.00%
NVDA1.99%
JNJ1.99%
META1.78%
AVGO1.74%
V1.69%
MSFT1.66%
COST1.56%

ETF Analysis

Fund Overview

JPMorgan U.S. Quality Factor ETF (JQUA) currently reports 288 stock positions (subject to change), placing it in the widely spread range by holdings breadth. The top line-up is XOM (2.17%), AAPL (2.09%), GOOGL (2.00%), with XOM as the largest single weight at 2.17%. Together, the top three holdings account for 6.26%, which points to a relatively flat weight distribution where no single cluster of names dominates outcomes. The weight distribution suggests a portfolio designed to capture thematic upside while avoiding excessive dependence on any single name outside the largest positions.

Profitability & Capital Efficiency

Assessing the quality of returns on invested capital, ROIC is 32.82%, WACC is 9.11%, and the economic spread is 23.71%. On balance, the portfolio's businesses are clearing their capital cost hurdle with room to spare. Supporting metrics show ROE at 44.60% and ROA at 11.25%, a combination that helps frame whether profitability strength is broad enough to hold through different market conditions. Taken together, the return profile suggests a portfolio with credible compounding capacity if current operating execution persists.

Valuation

The market currently prices the portfolio at trailing P/E of 24.94, forward P/E of 18.23, PEG of 2.33. The trailing and forward multiples diverge by a moderate amount, consistent with a market that sees improving earnings but is not extrapolating an aggressive growth path. The PEG ratio is consistent with a portfolio that is reasonably valued on a growth basis — not cheap, but not obviously expensive either. The current ratio of 1.84 is in an acceptable range, reflecting reasonable short-term financial health. Valuation and liquidity together frame a portfolio where the price paid today is a reasonable bet on earnings delivery — but not a margin-of-safety purchase at current levels.

Margins & Cash Generation

Looking at margins from gross to free cash flow, gross margin sits at 57.05%, operating margin at 27.53%, and free cash flow margin at 23.37%. Gross margins are constructive — not exceptional, but indicative of businesses with reasonable unit economics. At this level, operating margins reflect businesses that are scaling with discipline without dramatic cost pressure. The portfolio's cash conversion is solid — a sign that operating profits are translating into real liquidity at the fund level. All three margin layers are constructive, pointing to a portfolio where quality of earnings is high and cash generation is reliable.

Growth & Forward Outlook

Projected 12-month EPS growth of 36.8% adds a powerful forward signal — analyst consensus expects earnings to accelerate materially, which, if delivered, could make current multiples look increasingly modest. Turning to growth and analyst expectations, TTM revenue growth of 15.50% pointing to stable operational progress without outsized acceleration, while the estimated 12-month price change of 19.09%, where target prices point to mid-range appreciation potential from current levels. The distinction matters: revenue growth tells you what the businesses are doing, price targets tell you what analysts think the market will pay for it. Ultimately, the alignment between revenue momentum and analyst targets will depend on execution quality and the broader rate and sentiment environment. The estimated 12-month price change is a weighted composite of analyst price target estimates adjusted by each holding's ETF weight, sourced from publicly available data, and should not be interpreted as a reliable prediction of future performance.

Conclusion

Strong Buy

The quantitative profile, taken as a whole, is above average on virtually every dimension that matters for long-term return generation.

The views expressed above are derived from quantitative data only and should not be relied upon as financial advice. Investment decisions should be based on your own research and risk tolerance.